Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00340054 · ClinicalTrials.gov registry record
Developing Interview Questions to Estimate Workplace Exposure to Electric and Magnetic Fields
A clinical trial of Brain and Central Nervous System Tumors, sponsored by National Institutes of Health Clinical Center (CC).
- Completed
- Registry status
- 108
- Enrollment target
- 2
- Study locations
NCT00340054 is a study of Brain and Central Nervous System Tumors that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 108 participants, below the 181-participant average among 45 other Brain and Central Nervous System Tumors trials with a reported enrollment target (40% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00340054, a study of Brain and Central Nervous System Tumors, has completed, sponsored by National Institutes of Health Clinical Center (CC).
- COMPLETED
- Registry status
- 108 participants
- Enrollment target
- 2
- Study locations
Study Summary
RATIONALE: Electric and magnetic fields may increase the risk of cancer. Developing interview questions that accurately estimate a person's exposure to electric and magnetic fields may help doctors learn about the long-term effects of workplace exposure. PURPOSE: This clinical trial is developing interview questions that can be used in estimating workplace exposure to electric and magnetic fields.
Conditions Studied
Interventions
- OTHER questionnaire administration
- PROCEDURE study of high risk factors
Study Locations (2)
California
- Exponent, Inc. - Menlo Park
Ohio
- National Institute for Occupational Safety and Health - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2005-10 |
| Est. Completion | 2007-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00340054
The ClinicalTrials.gov registry entry for NCT00340054 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 181-participant average among 45 other Brain and Central Nervous System Tumors trials with a reported enrollment target (40% lower). The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Brain and Central Nervous System Tumors appearing as the primary indexed condition, and to 2 interventions - of which questionnaire administration is the first listed.
NCT00340054 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Ohio.
Frequently Asked Questions
What is clinical trial NCT00340054 about?
NCT00340054 is a clinical study titled "Developing Interview Questions to Estimate Workplace Exposure to Electric and Magnetic Fields". RATIONALE: Electric and magnetic fields may increase the risk of cancer. Developing interview questions that accurately estimate a person's exposure to electric and magnetic fields may help doctors learn about the long-term effects of workplace exposure. PURPOSE: This clinical trial is developing i...
What is the current status of trial NCT00340054?
This trial is currently completed. The enrollment target is 108 participants. The study started on 2005-10. Estimated completion is 2007-03.
What conditions does trial NCT00340054 study?
This clinical trial studies the following conditions: Brain and Central Nervous System Tumors.
What interventions are being tested in trial NCT00340054?
The interventions under investigation include: questionnaire administration (OTHER), study of high risk factors (PROCEDURE).
Who is sponsoring clinical trial NCT00340054?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00340054 being conducted?
This trial has 2 study locations across California, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Brain and Central Nervous System Tumors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
RECRUITING
-
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
ACTIVE NOT RECRUITING · Phase 3
-
Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH)
ACTIVE NOT RECRUITING · Phase 3
-
Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma
ACTIVE NOT RECRUITING · Phase 2
-
Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma
ACTIVE NOT RECRUITING · Phase 3
-
Immunotoxin Therapy in Treating Patients With Malignant Glioma
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.